Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
Business Of Biotech
00:00
How to Hire Regulatory and Other Need to Know Topics for Bio Pharma Leaders
The goal is less to be competitive on the price side. We would see more the value for our potential partners in the fact that if they have a difficult protein, we might do the trick with our technology. As far as like that, complexity is concerned and the partners that might be a good fit. Have you been able to identify any specific sort of therapeutic areas or or modality therapeutic approaches that would be a likely a more likely fit for you than others?
Transcript
Play full episode
